US: AIHLF - Adcock Ingram Holdings Limited

Yield per half year: 0%

Share chart Adcock Ingram Holdings Limited


About

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

more details
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

EBITDA 17.94
EV/EBITDA 0.6991
Industry Pharmaceuticals
P/BV 0.161
P/E 1.08
P/S 0.0994
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 127.25
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Число акций ао 0.15463 млрд
Change price per day: 0% (2.45)
Change price per week: 0% (2.45)
Change price per month: 0% (2.45)
Change price per 3 month: 0% (2.45)
Change price per half year: 0% (2.45)
Change price per year: 0% (2.45)
Change price per 3 year: -21.97% (3.14)
Change price per 5 year: -43.16% (4.31)
Change price per 10 year: 0% (2.45)
Change price per year to date: 0% (2.45)

Underestimation

Title Value Grade
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
Total: 8.63

Efficiency

Title Value Grade
ROA, % 1.02 1
ROE, % 1.58 1
Total: 1.67

Dividends

Title Value Grade
Div yield, % 166.72 10
DSI 0.8571 8.57
Total: 8.51

Debt

Title Value Grade
Debt/EBITDA 3.55 3
Total: 5.8

Growth impulse

Title Value Grade
Yield Revenue, % -92.9 0
Yield Ebitda, % -92.56 0
Yield EPS, % 20.99 4
Total: 0.8

Head Job title Payment Year of birth
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 years)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 year)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 years)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

Address: South Africa, Midrand, 1 New Road - open in Google maps, open in Yandex maps
Website: https://www.adcock.co.za